Next Weeks Broker Price Targets For Gilead Sciences, Inc. (NASDAQ:GILD)

Cornelia Mascio
Mag 31, 2017

The Gabalex Capital Management Llc holds 225,000 shares with $16.11M value, down from 275,000 last quarter. The stock has a market cap of $84.28 billion, a PE ratio of 6.82 and a beta of 1.11. (NASDAQ:GILD) was down -0.02% during the last trading session, with a day high of 64.77. About shares traded. New York Community Bancorp, Inc.

Gilead Sciences (NASDAQ:GILD) last issued its quarterly earnings data on Tuesday, May 2nd. It has underperformed by 38.50% the S&P500. Boston Private Wealth Llc reported 199,554 shares. About 1,855 shares traded. Cohen Klingenstein Ltd Company holds 13,184 shares or 0.16% of its portfolio. The stock increased 9.49% or $0.75 on May 30, reaching $8.65. Sullivan Bruyette Speros & Blaney LLC increased its position in Gilead Sciences by 0.6% in the fourth quarter. (NASDAQ:GILD) by 13.4% during the first quarter, Holdings Channel reports. The Riverbridge Partners Llc holds 3.29 million shares with $23.36 million value, up from 2.36 million last quarter. GILD's profit will be $2.78B for 7.57 P/E if the $2.13 EPS becomes a reality. After having $2.20 EPS previously, Gilead Sciences, Inc.'s analysts see -3.18 % EPS growth. Therefore 83% are positive. Equities research analysts expect that Gilead Sciences, Inc. will post $8.21 earnings per share for the current fiscal year. Gilead Sciences presently has a consensus rating of "Buy" and a consensus price target of $80.61. Morgan Stanley decreased their target price on Gilead Sciences from $85.00 to $77.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 8th. (NASDAQ:GILD) rating on Wednesday, September 14. RBC Capital Markets maintained the shares of GILD in report on Monday, October 3 with "Outperform" rating. The firm earned "Underperform" rating on Wednesday, December 21 by FBR Capital. The rating was initiated by Berenberg on Monday, September 12 with "Buy". Brown Brothers Harriman & Co. now owns 5,117 shares of the biopharmaceutical company's stock worth $405,000 after buying an additional 46 shares in the last quarter. The rating was maintained by UBS with "Buy" on Friday, April 29. Jefferies has "Buy" rating and $95 target.

Investors of record on Friday, June 16th will be given a dividend of $0.52 per share. Its down 0.23, from 0.93 in 2016Q3. It dived, as 106 investors sold GILD shares while 656 reduced holdings. 111 funds opened positions while 421 raised stakes.

Oppenheimer & Company Inc, which manages about $8.66B and $3.44 billion US Long portfolio, upped its stake in Alphabet Inc by 5,114 shares to 28,818 shares, valued at $22.84 million in 2016Q4, according to the filing. Whittier Tru Com Of Nevada accumulated 0.71% or 93,850 shares. Hillsdale Investment Management owns 0.07% invested in Gilead Sciences, Inc. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. (NASDAQ:GILD). Lazard Asset Management Ltd Co holds 0% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 1.55 million shares. Robshaw & Julian Associates Inc invested 1.88% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). 212,995 are owned by Muhlenkamp. Security National Company owns 31,849 shares for 0.82% of their portfolio. (NASDAQ:GILD) for 2,922 shares. Signature stated it has 4,229 shares. Nbt Bank N A NY owns 13,587 shares. Cable Hill Partners LLC increased its position in Gilead Sciences by 51.9% in the first quarter. Peak6 Invests LP stated it has 32,440 shares. Partnervest Advisory Services LLC boosted its stake in Gilead Sciences by 24.6% in the third quarter.

Since December 1, 2016, it had 0 buys, and 9 sales for $28.57 million activity. 9,943 shares were sold by Cogan John Francis, worth $668,667. (NASDAQ:GILD) was sold by MARTIN JOHN C. On Thursday, February 23 WILSON GAYLE E sold $1.41 million worth of Gilead Sciences, Inc. Another trade for 140,372 shares valued at $20.26 million was made by Menear Craig A on Wednesday, February 22. Alton Gregg H sold 5,000 shares worth $337,392. (NYSE:MD) stake by 29,855 shares and now owns 923,911 shares. It also reduced Mastercard Incorporated (NYSE:MA) stake by 79,520 shares and now owns 25,196 shares. (NASDAQ:LOPE) was reduced too. Its up 10.76, from 1.01 in 2016Q3. 61 funds opened positions while 164 raised stakes. Moreover, Corbyn Investment Md has 5.67% invested in MasTec, Inc. United Automobile Association invested in 1.18 million shares or 0.53% of the stock. Whittier Trust Company accumulated 895 shares or 0% of the stock. Louisiana State Employees Retirement Sys invested in 0.31% or 82,800 shares. Botty Ltd reported 4,220 shares. Oxford Asset Mgmt holds 0.49% or 255,015 shares in its portfolio. First Quadrant Limited Partnership Ca reported 71,361 shares or 0.2% of all its holdings. Morgan Stanley reported 0% of its portfolio in IntriCon Corporation (NASDAQ:IIN). Texas Yale Corp owns 5,460 shares. Proshare Ltd Com holds 0.36% in Home Depot Inc (NYSE:HD) or 244,627 shares. (NYSE:EFX). Mckinley Management Ltd Limited Liability Company Delaware holds 0.08% in Equifax Inc. Douglass Winthrop Advsrs stated it has 24,891 shares or 0.12% of all its holdings. Anchor Capital Advisors Llc, a Massachusetts-based fund reported 2.50 million shares. Therefore 73% are positive. Pillar Pacific Mngmt Limited Liability Company reported 1.15% of its portfolio in Gilead Sciences, Inc. (NYSE:EFX) on Friday, July 24 to "Neutral" rating. Wood has "Outperform" rating and $286 target. The stock has "Buy" rating by Stifel Nicolaus on Monday, November 14. The firm has "Neutral" rating given on Wednesday, February 8 by Citigroup. On Thursday, February 25 the stock rating was initiated by Citigroup with "Buy". The rating was downgraded by William Blair on Wednesday, January 11 to "Market Perform". Morgan Stanley has "Equal-Weight" rating and $127 target. Jefferies maintained Intercontinental Exchange Inc (NYSE:ICE) on Tuesday, April 11 with "Buy" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE